Can vs. Could

The effects of direct action of unconstitutionality no.5,529 on pharmaceutical patent terms

Autores

  • Michelle Baruhm Diegues Universidade de São Paulo

DOI:

https://doi.org/10.11606/issn.0102-8049.i187p%25p

Palavras-chave:

patent, intellectual property, pharmaceuticals, healthcare

Resumo

The landmark ruling of the Direct Action of Unconstitutionality No. 5,529 (DAU 5,529) declared the unconstitutionality of Section 40, sole paragraph, of the Brazilian Industrial Property Code, which proposed an automatic and indeterminate patent term extension. However, four years later, there has been no public effort to identify the patents affected by the decision and to monitor its implementation by the Brazilian patent office (INPI). This short paper therefore aims to begin filling this data gap through exploratory research, analyzing a sample of 500 patents whose protection periods were adjusted by the INPI. The hypothesis presented here is that the DAU 5,529 had very limited effects on expanding access to healthcare thus far, since most patents affected by the decision are still in force and patent holders have been using administrative strategies to extend their invention’s term. The results of the empirical research confirm the hypothesis and indicate that a more in-depth and comprehensive analysis of the outcomes of DAU 5,529 is necessary.

Downloads

Os dados de download ainda não estão disponíveis.

Referências

BRAZIL. Supreme Court. Direct Action of Unconstitutionality No. 5,529. Justice Rapporteur Dias Toffoli. Judged on May 12, 2021.

BRAZIL. Supreme Court. Proposal for modulation of the effects of DAU 5,529. Justice Rapporteur Dias Toffoli. Judged on May 12, 2021.

CABRAL, Mário André Machado. Automatic Patent Term Extensions Ruled Unconstitutional in Brazil: better late than never? IIC – International Review Of Intellectual Property And Competition Law, v. 53, n. 1, p. 160-168, January 2022.

CASTRO, Marcia C. et al. Brazil’s unified health system: the first 30 years and prospects for the future. The Lancet Health Policy, v. 394, n. 10195, p. 345-356, July 2019.

DIAS, Tatiana. Lobby contra quebra de patentes de medicamentos pagou R$ 1,5 milhão a jornais. The Intercept. April 28, 2021. Available at: <https://www.intercept.com.br/2021/04/28/lobby-contra-quebra-de-patentes-pagou-jornais/>. Access on January 28, 2024.

DREYFUSS, Rochelle; PILA, Justine. Intellectual Property Law: An Anatomical Overview. In: DREYFUSS, Rochelle; PILA, Justine (ed.). The Oxford Handbook of Intellectual Property Law. Oxford: Oxford University Press, 2018, p. 26-27.

GDP. Grupo Direito e Pobreza Repercutindo o Julgamento da Ação Direta de Inconstitucionalidade nº 5.529. May 17, 2021. Available at: <https://www.direitoepobreza.org.br/post/grupo-direito-e-pobreza-repercutindo-o-julgamento-da-a%C3%A7%C3%A3o-direta-de-inconstitucionalidade-n-5-529?fbclid=IwAR2og3sV7had vRcdsaDDJSrTeFDmEyNbMz28Bl-j6HfTLTDW5tObjNLBqrQ>. Access on January 29, 2024.

IDO, Vitor Henrique Pinto. The Role of Courts in Implementing TRIPS Flexibilities: Brazilian Supreme Court Rules Automatic Patent Term Extensions Unconstitutional. South Centre Policy Brief, n. 94, June 2021. Available at: <https://www.southcentre.int/wp-content/uploads/2021/06/PB-94-1.pdf>. Access on January 28, 2024.

LOCKE, John. Second Treatise of Government. Indianapolis: Hackett, 1980.

KENNEDY, David. The International Human Rights Movement: Part of the Problem? In: Harvard Human Rights Journal, v. 15, 2002, p. 101-125.

MINISTÉRIO DA SAÚDE. Aquisição de Medicamentos para Assistência Farmacêutica no SUS: Orientações básicas. Brasília: Círculo de Brasília, 2006. Available at: <http://www.ensp.fiocruz.br/portal-ensp/judicializacao/pdfs/284.pdf>. Access on January 28, 2024.

MIYAMOTO, Tomoko. International treaties and patent law harmonization: today and beyond. In: TAKENAKA, Toshiko (ed.). Research Handbook on Patent Law and Theory. Cheltenham: Edward Elgar, 2019.

PARANHOS, Julia; MERCADANTE, Eduardo; HASENCLEVER, Lia. O custo da extensão da vigência de patentes de medicamentos para o Sistema Único de Saúde. Cadernos de Saúde Pública, v. 36, n. 11, 2020. Available at: <https://www.scielo.br/j/csp/a/37vfpd7rVJzFDhzbnStQ9 YM/abstract/?lang=pt&format=html>. Access on January 28, 2024.

PORTUGAL GOUVÊA, Carlos. Análise dos Custos da Desigualde: Efeitos institucionais do círculo vicioso de desigualdade e corrupção. São Paulo: Quartier Latin, 2021.

__________. Heterodoxy of the Brazilian Supreme Court in Patent Law: A Blueprint for Opposing Neo-Archaism of Global Monopolies? No prelo.

PGF. Federal Attorney General's Office. Opinion No. 00047/2021/CGPI/PFE-INPI/PGF/AGU. November 3, 2021. Available at: <https://www.gov.br/inpi/pt-br/central-de-conteudo/legislacao/arquivos/documentos/parecer-n-00047-2021-cgpi-pfe-inpi-pgf-agu-com-carater-normativo.pdf>. Access on February 2, 2024.

SALOMÃO FILHO, Calixto; PORTUGAL GOUVÊA, Carlos et al. A Inconstitucionalidade do Artigo 40, Parágrafo Único, da Lei de Propriedade Industrial sob uma Perspectiva Comparada. December 8, 2020. Available at: <https://ssrn.com/abstract=3745372>. Access on January 28, 2024.

SHADLEN, Kenneth C.; SAMPAT, Bhaven N.; KAPCZYNSKI, Amy. Patents, trade and medicines: past, present and future. Review Of International Political Economy, v. 27, n. 1, p. 75-97, June 2019.

Publicado

2024-01-01

Como Citar

Baruhm Diegues, M. (2024). Can vs. Could: The effects of direct action of unconstitutionality no.5,529 on pharmaceutical patent terms. Revista De Direito Mercantil, 187, 277-300. https://doi.org/10.11606/issn.0102-8049.i187p%p